221 related articles for article (PubMed ID: 24236993)
1. Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats.
Pypendop BH; Ilkiw JE; Shilo-Benjamini Y
J Vet Pharmacol Ther; 2014 Jun; 37(3):295-300. PubMed ID: 24236993
[TBL] [Abstract][Full Text] [Related]
2. Effect of morphine, methadone, hydromorphone or oxymorphone on the thermal threshold, following intravenous or buccal administration to cats.
Pypendop BH; Shilo-Benjamini Y; Ilkiw JE
Vet Anaesth Analg; 2016 Nov; 43(6):635-642. PubMed ID: 27723230
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oxymorphone in cats.
Siao KT; Pypendop BH; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2011 Dec; 34(6):594-8. PubMed ID: 21323677
[TBL] [Abstract][Full Text] [Related]
5. Sublingual absorption of selected opioid analgesics.
Weinberg DS; Inturrisi CE; Reidenberg B; Moulin DE; Nip TJ; Wallenstein S; Houde RW; Foley KM
Clin Pharmacol Ther; 1988 Sep; 44(3):335-42. PubMed ID: 2458208
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats.
Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ
Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522
[TBL] [Abstract][Full Text] [Related]
7. Intranasal absorption of oxymorphone.
Hussain MA; Aungst BJ
J Pharm Sci; 1997 Aug; 86(8):975-6. PubMed ID: 9269879
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study.
Bateman SW; Haldane S; Stephens JA
Vet Anaesth Analg; 2008 Jul; 35(4):341-7. PubMed ID: 18363580
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
Linardi RL; Stokes AM; Keowen ML; Barker SA; Hosgood GL; Short CR
Am J Vet Res; 2012 Feb; 73(2):290-5. PubMed ID: 22280392
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.
Smith LJ; Kukanich BK; Krugner-Higby LA; Schmidt BH; Heath TD
Vet Anaesth Analg; 2013 Sep; 40(5):537-45. PubMed ID: 23601353
[TBL] [Abstract][Full Text] [Related]
12. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
13. [Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
[TBL] [Abstract][Full Text] [Related]
14. Comparison of histamine release induced by morphine and oxymorphone administration in dogs.
Robinson EP; Faggella AM; Henry DP; Russell WL
Am J Vet Res; 1988 Oct; 49(10):1699-701. PubMed ID: 2461130
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
Coda BA; Rudy AC; Archer SM; Wermeling DP
Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
[TBL] [Abstract][Full Text] [Related]
16. Effect of amantadine on oxymorphone-induced thermal antinociception in cats.
Siao KT; Pypendop BH; Escobar A; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2012 Apr; 35(2):169-74. PubMed ID: 21535013
[TBL] [Abstract][Full Text] [Related]
17. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxymorphone hydrochloride or hydromorphone hydrochloride on minimal alveolar concentration of desflurane in sheep.
Sayre RS; Lepiz MA; Horsley KT; Pashmakova MB; Barr JW; Washburn SE
Am J Vet Res; 2015 Jul; 76(7):583-90. PubMed ID: 26111087
[TBL] [Abstract][Full Text] [Related]
20. The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Reddy A; Vidal M; Stephen S; Baumgartner K; Dost S; Nguyen A; Heung Y; Kwan S; Wong A; Pangemanan I; Azhar A; Tayjasanant S; Rodriguez E; Waletich J; Lim KH; Wu J; Liu D; Williams J; Yennurajalingam S; Bruera E
J Pain Symptom Manage; 2017 Sep; 54(3):280-288. PubMed ID: 28711751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
